This prognostic study of patients with cancer in the Netherlands describes the development and internal-external validation of a prognostic model to calculate the 1-year risk of death among patients with advanced cancer.
Recent Posts
- Coseropositivity to Tick-Borne Pathogens in Patients Suspected to Have Lyme Disease
- Urban and Rural Hospital Closures in Georgia, 2022-2024
- Single- vs Multiple-Dose Antibiotic Prophylaxis for Total Hip Arthroplasty
- Maternal Outcomes Among Periviable Births by Cesarean Delivery
- RSV Vaccine Effectiveness Among US Older Adults, 2023-2024 Season